• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾酶是一种 α-NAD(P)H 氧化酶/差向异构酶。

Renalase is an α-NAD(P)H oxidase/anomerase.

机构信息

Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee , 3210 N. Cramer Street, Milwaukee, Wisconsin 53211-3209, United States.

出版信息

J Am Chem Soc. 2013 Sep 18;135(37):13980-7. doi: 10.1021/ja407384h. Epub 2013 Sep 5.

DOI:10.1021/ja407384h
PMID:23964689
Abstract

Renalase is a protein hormone secreted into the blood by the kidney that is reported to lower blood pressure and slow heart rate. Since its discovery in 2005, renalase has been the subject of conjecture pertaining to its catalytic function. While it has been widely reported that renalase is the third monoamine oxidase (monoamine oxidase C) that oxidizes circulating catecholamines such as epinephrine, there has been no convincing demonstration of this catalysis in vitro. Renalase is a flavoprotein whose structural topology is similar to known oxidases, lysine demethylases, and monooxygenases, but its active site bears no resemblance to that of any known flavoprotein. We have identified the catalytic activity of renalase as an α-NAD(P)H oxidase/anomerase, whereby low equilibrium concentrations of the α-anomer of NADPH and NADH initiate rapid reduction of the renalase flavin cofactor. The reduced cofactor then reacts with dioxygen to form hydrogen peroxide and releases nicotinamide dinucleotide product in the β-form. These processes yield an apparent turnover number (0.5 s(-1) in atmospheric dioxygen) that is at least 2 orders of magnitude more rapid than any reported activity with catechol neurotransmitters. This highly novel activity is the first demonstration of a role for naturally occurring α-NAD(P)H anomers in mammalian physiology and the first report of a flavoprotein catalyzing an epimerization reaction.

摘要

肾酶是一种由肾脏分泌到血液中的蛋白质激素,据报道可降低血压和心率。自 2005 年发现以来,肾酶的催化功能一直是人们猜测的主题。虽然广泛报道肾酶是第三种单胺氧化酶(单胺氧化酶 C),可氧化循环中的儿茶酚胺,如肾上腺素,但尚未在体外对此催化作用进行令人信服的证明。肾酶是一种黄素蛋白,其结构拓扑与已知的氧化酶、赖氨酸去甲基酶和单加氧酶相似,但它的活性位点与任何已知的黄素蛋白都没有相似之处。我们已经确定了肾酶的催化活性为 α-NAD(P)H 氧化酶/差向异构酶,其中 α-NADPH 和 NADH 的低平衡浓度会迅速还原肾酶黄素辅因子。然后,还原的辅因子与氧气反应形成过氧化氢,并以 β-形式释放烟酰胺二核苷酸产物。这些过程产生的表观周转率(在大气氧气中为 0.5 s(-1))比任何报道的儿茶酚神经递质活性至少快 2 个数量级。这种高度新颖的活性首次证明了天然存在的 α-NAD(P)H 差向异构体在哺乳动物生理学中的作用,并且首次报道了一种黄素蛋白催化差向异构化反应。

相似文献

1
Renalase is an α-NAD(P)H oxidase/anomerase.肾酶是一种 α-NAD(P)H 氧化酶/差向异构酶。
J Am Chem Soc. 2013 Sep 18;135(37):13980-7. doi: 10.1021/ja407384h. Epub 2013 Sep 5.
2
Kinetics and equilibria of the reductive and oxidative half-reactions of human renalase with α-NADPH.人肾酶与α-NADPH 的还原和氧化半反应的动力学和平衡。
Biochemistry. 2013 Dec 10;52(49):8929-37. doi: 10.1021/bi401185m. Epub 2013 Nov 27.
3
Bacterial Renalase: Structure and Kinetics of an Enzyme with 2- and 6-Dihydro-β-NAD(P) Oxidase Activity from Pseudomonas phaseolicola.细菌肾酶:来自花生假单胞菌的具有 2-和 6-二氢-β-NAD(P)氧化酶活性的一种酶的结构和动力学。
Biochemistry. 2015 Jun 23;54(24):3791-802. doi: 10.1021/acs.biochem.5b00451. Epub 2015 Jun 9.
4
[The history of renalase from amine oxidase to a a-NAD(P)H-oxidase/anomerase].[肾酶从胺氧化酶到α-NAD(P)H氧化酶/异头酶的历史]
Biomed Khim. 2015 Nov-Dec;61(6):667-79. doi: 10.18097/PBMC20156106667.
5
Metabolic function for human renalase: oxidation of isomeric forms of β-NAD(P)H that are inhibitory to primary metabolism.人肾酶的代谢功能:对初级代谢有抑制作用的β-NAD(P)H异构体的氧化。
Biochemistry. 2015 Jan 27;54(3):795-806. doi: 10.1021/bi5013436. Epub 2015 Jan 8.
6
Renalase does not catalyze the oxidation of catecholamines.肾酶不催化儿茶酚胺的氧化。
Arch Biochem Biophys. 2015 Aug 1;579:62-6. doi: 10.1016/j.abb.2015.05.016. Epub 2015 Jun 3.
7
FAD-binding site and NADP reactivity in human renalase: a new enzyme involved in blood pressure regulation.人肾素 FAD 结合位点和 NADP 反应性:一种新的参与血压调节的酶。
J Mol Biol. 2011 Aug 12;411(2):463-73. doi: 10.1016/j.jmb.2011.06.010. Epub 2011 Jun 14.
8
The catalytic function of renalase: A decade of phantoms.肾酶的催化功能:十年幻影。
Biochim Biophys Acta. 2016 Jan;1864(1):177-86. doi: 10.1016/j.bbapap.2015.04.010. Epub 2015 Apr 18.
9
Pyridoxamine-phosphate oxidases and pyridoxamine-phosphate oxidase-related proteins catalyze the oxidation of 6-NAD(P)H to NAD(P).吡哆醛-5-磷酸氧化酶和吡哆醛-5-磷酸氧化酶相关蛋白催化 6-NAD(P)H 氧化为 NAD(P)。
Biochem J. 2019 Oct 30;476(20):3033-3052. doi: 10.1042/BCJ20190602.
10
The enzyme: Renalase.这种酶:肾酶。
Arch Biochem Biophys. 2017 Oct 15;632:66-76. doi: 10.1016/j.abb.2017.05.015. Epub 2017 May 27.

引用本文的文献

1
Comprehensive molecular analysis of early‑onset gastric cancer identifies novel genes implicated in disease characterization and progression (Review).早发性胃癌的综合分子分析确定了与疾病特征和进展相关的新基因(综述)。
Oncol Rep. 2025 Aug;54(2). doi: 10.3892/or.2025.8931. Epub 2025 Jun 20.
2
The early diagnostic value of serum renalase level in diabetic kidney disease and diabetic macroangiopathy: a retrospective case-control study.血清肾酶水平在糖尿病肾病和糖尿病大血管病变中的早期诊断价值:一项回顾性病例对照研究。
Ther Adv Chronic Dis. 2024 Oct 16;15:20406223241286677. doi: 10.1177/20406223241286677. eCollection 2024.
3
Renalase rs2296545 variant improve hypertension susceptibility by modifying binding affinity to catecholamines in obstructive sleep apnea.
肾酶 rs2296545 变异通过改变与阻塞性睡眠呼吸暂停儿茶酚胺的结合亲和力来改善高血压易感性。
Hypertens Res. 2024 Nov;47(11):3200-3213. doi: 10.1038/s41440-024-01850-0. Epub 2024 Sep 4.
4
Relation Between Exposure to Tobacco Smoke Assessed by Serum Cotinine Concentration and Questionnaire Method, and Serum Renalase Concentration-the Importance of the Coexistence of Arterial Hypertension and Other Cardiovascular Diseases.血清可替宁浓度评估的吸烟暴露与问卷调查法和血清肾素酶浓度之间的关系——动脉高血压和其他心血管疾病共存的重要性。
Cardiovasc Toxicol. 2024 Aug;24(8):737-746. doi: 10.1007/s12012-024-09868-z. Epub 2024 May 15.
5
Coexistence of Cardiovascular Risk Factors and Blood Renalase Concentration.心血管危险因素与血液肾素浓度共存。
Int J Mol Sci. 2023 Nov 23;24(23):16666. doi: 10.3390/ijms242316666.
6
The Multi-Faceted Nature of Renalase for Mitochondrial Dysfunction Improvement in Cardiac Disease.肾酶在改善心脏疾病中线粒体功能障碍方面的多效性。
Cells. 2023 Jun 12;12(12):1607. doi: 10.3390/cells12121607.
7
Renalase Challenges the Oxidative Stress and Fibroproliferative Response in COVID-19.肾钠肽在 COVID-19 中的氧化应激和纤维增生反应。
Oxid Med Cell Longev. 2022 Sep 12;2022:4032704. doi: 10.1155/2022/4032704. eCollection 2022.
8
Renalase: a novel regulator of cardiometabolic and renal diseases.肾酶:一种调节心脏代谢和肾脏疾病的新型调节剂。
Hypertens Res. 2022 Oct;45(10):1582-1598. doi: 10.1038/s41440-022-00986-1. Epub 2022 Aug 8.
9
The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis.肾酶引入心脏纤维化概念的科学依据。
Front Cardiovasc Med. 2022 May 31;9:845878. doi: 10.3389/fcvm.2022.845878. eCollection 2022.
10
Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease.肾酶(β-NAD(P)H 异构酶)水平升高可作为慢性肾脏病患者发生主要不良心血管事件和全因死亡的危险因素。
Biomolecules. 2021 Oct 14;11(10):1514. doi: 10.3390/biom11101514.